{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:09:34Z","timestamp":1790831374536,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001411","name":"ICMR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Long-term functional outcomes in enthesitis-related arthritis (ERA) is limited from developing countries. We assessed the clinical and genetic factors that predicted the long-term functional outcome in ERA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients with ERA having \u22655\u2009years of disease and &amp;gt;16\u2009years of age were included in this cross-sectional study. Data on clinical features within 6\u2009months of disease onset was collected from hospital records. Bath indices, HAQ Disability Index (HAQ-DI) and World Health Organization\u2019s Quality of Life (WHO-QOL) were assessed at last visit. Poor functional outcome (PFO) was defined as BASFI\u2009&amp;gt;\u20091.5 or HAQ-DI\u2009&amp;gt;\u20091. Persistent disease activity (PDA) was defined as BASDAI\u2009\u2265\u20094. Endoplasmic reticulum aminopeptidase 1 (ERAP1) and IL-23 receptor single nucleotide polymorphism genotyping was performed with the TaqMan method and HLA-B27 by PCR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>One hundred and eighty-one patients [170 male, median (interquartile range) age of disease onset 12.5 (10\u201315) years, disease duration 7 (5\u201311) years] were recruited. There was a delay in diagnosis of 3 (1\u20135) years. The median Ankylosing Spondylitis Disease Activity Score (ASDAS)-ESR, BASDAI, HAQ-DI and BASFI at inclusion were 2.6 (1.8\u20133.6), 2.6 (1\u20135.2), 0.5 (0\u20130.5) and 1.6 (0.3\u20133.2), respectively. BASFI and HAQ-DI correlated with ASDAS-ESR, ASDAS-CRP and WHO-QOL-BREF. Those with PFO (n\u2009=\u200998) had a longer delay in diagnosis (4 vs 2\u2009years, P\u2009&amp;lt;\u20090.001), lower prevalence of arthritis at onset [odds ratio (OR)\u2009=\u20090.3; 95% CI: 0.1, 0.8], higher prevalence of ERAP1 (rs27044) allele C (OR\u2009=\u20097.2; 95% CI: 1.5, 33.7) and higher disease activity currently. Delay in diagnosis (OR\u2009=\u20091.2; 95% CI: 1.08, 1.4) was the sole predictor of PFO in multivariate analysis. One-third of patients had PDA. Tarsitis at disease onset was the sole predictor of PDA (OR\u2009=\u20092.3; 95% CI: 1.009, 5.4).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>PFO was seen in one-half of JIA-ERA in the long-term and was associated with active disease with delay in diagnosis as its sole predictor.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/kead032","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T21:13:52Z","timestamp":1674594832000},"page":"3110-3116","source":"Crossref","is-referenced-by-count":11,"title":["Predictors of long-term functional outcomes of juvenile idiopathic arthritis\u2013enthesitis-related arthritis: a single centre experience"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2014-3925","authenticated-orcid":false,"given":"Naveen","family":"Ravichandran","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences , Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivika","family":"Guleria","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences , Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namita","family":"Mohindra","sequence":"additional","affiliation":[{"name":"Department of Radiodiagnosis, Sanjay Gandhi Postgraduate Institute of Medical Sciences , Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2187-5186","authenticated-orcid":false,"given":"Amita","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences , Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"key":"2023090115155304200_kead032-B1","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s10067-015-3029-4","article-title":"Enthesitis related arthritis","volume":"34","author":"Aggarwal","year":"2015","journal-title":"Clin Rheumatol"},{"key":"2023090115155304200_kead032-B2","doi-asserted-by":"crossref","first-page":"11756","DOI":"10.3899\/jrheum.090937","article-title":"Profile of Indian patients with juvenile onset chronic inflammatory joint disease using the ILAR classification criteria for JIA: a community-based cohort study","volume":"37","author":"Kunjir","year":"2010","journal-title":"J Rheumatol"},{"key":"2023090115155304200_kead032-B3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00300247","article-title":"Juvenile chronic arthritis in India: is it different from that seen in Western countries?","volume":"14","author":"Aggarwal","year":"1994","journal-title":"Rheumatol Int"},{"key":"2023090115155304200_kead032-B4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/acr.23853","article-title":"Long-term outcomes in juvenile idiopathic arthritis: 18 years of follow-up in the population-based Nordic Juvenile Idiopathic Arthritis (JIA) cohort","volume":"72","author":"Glerup","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2023090115155304200_kead032-B5","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/rheumatology\/kes004","article-title":"Functional status in severe juvenile idiopathic arthritis in the biologic treatment era: an assessment in a French paediatric rheumatology referral centre","volume":"51","author":"Boiu","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2023090115155304200_kead032-B6","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1002\/art.34499","article-title":"The relationships between adult juvenile idiopathic arthritis and employment","volume":"64","author":"Malviya","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2023090115155304200_kead032-B7","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1002\/art.22181","article-title":"Long-term outcome and prognostic factors in enthesitis-related arthritis: a case-control study","volume":"54","author":"Flat\u00f8","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2023090115155304200_kead032-B8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3899\/jrheum.121257","article-title":"HLA-B27 predicts a more chronic disease course in an 8-year followup cohort of patients with juvenile idiopathic arthritis","volume":"40","author":"Berntson","year":"2013","journal-title":"J Rheumatol"},{"key":"2023090115155304200_kead032-B9","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3390\/jcm10040568","article-title":"Enthesitis related arthritis in a Longitudinal Southeast Asian Registry: high prevalence of HLA-B27, different sacroiliitis risk factors and less common drug-free remission","volume":"10","author":"Arkachaisri","year":"2021","journal-title":"J Clin Med"},{"key":"2023090115155304200_kead032-B10","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar3235","article-title":"Subtype specific genetic associations for juvenile idiopathic arthritis: ERAP1 with the enthesitis related arthritis subtype and IL23R with juvenile psoriatic arthritis","volume":"13","author":"Hinks","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"2023090115155304200_kead032-B11","doi-asserted-by":"crossref","first-page":"681621","DOI":"10.3389\/fmed.2021.681621","article-title":"Similarities and differences between juvenile and adult spondyloarthropathies","volume":"8","author":"Fisher","year":"2021","journal-title":"Front Med"},{"key":"2023090115155304200_kead032-B12","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s10067-017-3560-6","article-title":"ERAP1 rs30187 single nucleotide polymorphism does not confer disease susceptibility in North Indian children with enthesitis-related arthritis","volume":"36","author":"Srivastava","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2023090115155304200_kead032-B13","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"2023090115155304200_kead032-B14","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1002\/acr.20575","article-title":"Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S)","volume":"63(Suppl 11)","author":"Zochling","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2023090115155304200_kead032-B15","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/annrheumdis-2012-202976","article-title":"Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme","volume":"73","author":"Fern\u00e1ndez-Espartero","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2023090115155304200_kead032-B16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1477-7525-1-20","article-title":"The Stanford Health Assessment Questionnaire: dimensions and practical applications","volume":"1","author":"Bruce","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"2023090115155304200_kead032-B17","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/art.21119","article-title":"Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis","volume":"52","author":"Viola","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2023090115155304200_kead032-B18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12955-020-01656-x","article-title":"Validation of the WHOQOL-Bref: psychometric properties and normative data for the Norwegian general population","volume":"19","author":"Kalfoss","year":"2021","journal-title":"Health Qual Life Outcomes"},{"key":"2023090115155304200_kead032-B19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2474-13-40","article-title":"Normative values for the bath ankylosing spondylitis functional index in the general population compared with ankylosing spondylitis patients in Morocco","volume":"13","author":"Wariaghli","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"2023090115155304200_kead032-B20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1034\/j.1399-0039.1999.530208.x","article-title":"Molecular typing for HLA class I using ARMS-PCR: further developments following the 12th International Histocompatibility Workshop","volume":"53","author":"Tonks","year":"2002","journal-title":"Tissue Antigens"},{"key":"2023090115155304200_kead032-B21"},{"key":"2023090115155304200_kead032-B22","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1007\/s10067-021-05807-3","article-title":"Hip involvement in children with enthesitis related arthritis (ERA) is associated with poor outcomes in adulthood","volume":"40","author":"Naveen","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2023090115155304200_kead032-B23","doi-asserted-by":"crossref","first-page":"e000366","DOI":"10.1136\/rmdopen-2016-000366","article-title":"Course of patients with juvenile spondyloarthritis during 4 years of observation, juvenile part of GESPIC","volume":"3","author":"Wei\u00df","year":"2017","journal-title":"RMD Open"},{"key":"2023090115155304200_kead032-B24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1546-0096-6-18","article-title":"Outcome in patients with enthesitis related arthritis (ERA): juvenile arthritis damage index (JADI) and functional status","volume":"6","author":"Sarma","year":"2008","journal-title":"Pediatr Rheumatol"},{"key":"2023090115155304200_kead032-B25","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1002\/art.38440","article-title":"A24: validation of BASDAI and BASFI in children with spondyloarthritis","volume":"66","author":"Rachlis","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2023090115155304200_kead032-B26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/1756-185X.12989","article-title":"Validity and reliability of the Health Assessment Questionnaire among patients with spondyloarthritis in Singapore","volume":"21","author":"Kwan","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"2023090115155304200_kead032-B27","first-page":"192","article-title":"Axial involvement in the seronegative enthesopathy and arthropathy syndrome and its progression to ankylosing spondylitis","volume":"16","author":"Burgos-Vargas","year":"1989","journal-title":"J Rheumatol"},{"key":"2023090115155304200_kead032-B28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/ard.43.3.381","article-title":"Ankylosing spondylitis in North India: a clinical and immunogenetic study","volume":"43","author":"Prakash","year":"1984","journal-title":"Ann Rheum Dis"},{"key":"2023090115155304200_kead032-B29","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00296-016-3529-9","article-title":"HLA B27 typing in 511 children with juvenile idiopathic arthritis from India","volume":"36","author":"Srivastava","year":"2016","journal-title":"Rheumatol Int"},{"key":"2023090115155304200_kead032-B30","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/art.1780380618","article-title":"The early clinical recognition of juvenile-onset ankylosing spondylitis and its differentiation from juvenile rheumatoid arthritis","volume":"38","author":"Burgos-Vargas","year":"1995","journal-title":"Arthritis Rheum"},{"key":"2023090115155304200_kead032-B31","doi-asserted-by":"crossref","first-page":"680916","DOI":"10.3389\/fmed.2021.680916","article-title":"Outcomes in juvenile-onset spondyloarthritis","volume":"8","author":"Smith","year":"2021","journal-title":"Front Med"},{"key":"2023090115155304200_kead032-B32","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s10067-017-3733-3","article-title":"Prominent midfoot involvement in children with enthesitis-related arthritis category of juvenile idiopathic arthritis","volume":"36","author":"Phatak","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2023090115155304200_kead032-B33","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/acr.20508","article-title":"Enthesitis in an inception cohort of enthesitis-related arthritis","volume":"63","author":"Weiss","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead032\/49088127\/kead032.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/9\/3110\/51329127\/kead032.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/9\/3110\/51329127\/kead032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T15:40:32Z","timestamp":1693582832000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/9\/3110\/7005193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,1,25]]},"published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead032","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9,1]]},"published":{"date-parts":[[2023,1,25]]}}}